These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3778276)
41. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma. Luyten GP; Mooy CM; Eijkenboom WM; Stijnen T; Hellemons LP; Luider TM; de Jong PT Am J Ophthalmol; 1995 Jun; 119(6):786-91. PubMed ID: 7785695 [TBL] [Abstract][Full Text] [Related]
42. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594 [TBL] [Abstract][Full Text] [Related]
43. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Coupland SE; Campbell I; Damato B Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722 [TBL] [Abstract][Full Text] [Related]
44. Very long-term prognosis of patients with malignant uveal melanoma. Kujala E; Mäkitie T; Kivelä T Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381 [TBL] [Abstract][Full Text] [Related]
45. Uveal melanoma prognostication: from lesion size and cell type to molecular class. Gill HS; Char DH Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301 [TBL] [Abstract][Full Text] [Related]
46. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
47. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322 [TBL] [Abstract][Full Text] [Related]
48. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups. Augsburger JJ; Gamel JW; Shields JA Trans Am Ophthalmol Soc; 1989; 87():348-59; discussion 359-61. PubMed ID: 2562523 [No Abstract] [Full Text] [Related]
49. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
50. Epigenetic inactivation of RASSF1a in uveal melanoma. Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440 [TBL] [Abstract][Full Text] [Related]
51. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas. van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553 [TBL] [Abstract][Full Text] [Related]
52. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. Bidard FC; Madic J; Mariani P; Piperno-Neumann S; Rampanou A; Servois V; Cassoux N; Desjardins L; Milder M; Vaucher I; Pierga JY; Lebofsky R; Stern MH; Lantz O Int J Cancer; 2014 Mar; 134(5):1207-13. PubMed ID: 23934701 [TBL] [Abstract][Full Text] [Related]
53. Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. White JS; McLean IW; Becker RL; Director-Myska AE; Nath J Cancer Genet Cytogenet; 2006 Oct; 170(1):29-39. PubMed ID: 16965952 [TBL] [Abstract][Full Text] [Related]